Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2013, Article ID 513049, 3 pages
http://dx.doi.org/10.1155/2013/513049
Case Report

BRAF V600E-Negative Hairy Cell Leukaemia

1Cancer Molecular Diagnostics, Central Pathology Laboratory, St. James’s Hospital, Dublin 8, Ireland
2Department of Haematology, St. James’s Hospital, Dublin, Ireland
3Department of Haematology, Trinity College Dublin, Dublin, Ireland

Received 8 February 2013; Accepted 25 March 2013

Academic Editors: E. Arellano-Rodrigo, G. Pihan, D. Rund, and S. D. Wagner

Copyright © 2013 Stephen E. Langabeer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Tiacci, V. Trifonov, G. Schiavoni et al., “BRAF mutations in hairy-cell leukemia,” The New England Journal of Medicine, vol. 364, no. 24, pp. 2305–2315, 2011. View at Google Scholar
  2. T. Tadmor, E. Tiacci, B. Falini, and A. Polliack, “The BRAF-V600E mutation in hematological malignancies: a new placer in hairy cell leukemia and Langerhans cell histiocytosis,” Leukemia & Lymphoma, vol. 53, no. 12, pp. 2339–2340, 2012. View at Google Scholar
  3. S. E. Langabeer, D. O’Brien, S. Liptrot et al., “Correlation of the BRAF V600E mutation in hairy cell leukaemia with morphology, cytochemistry and immunophenotype,” International Journal of Laboratory Hematology, vol. 34, no. 4, pp. 417–421, 2012. View at Google Scholar
  4. Y. H. Chen, M. S. Tallman, C. Goolsby, and L. Peterson, “Immunophenotypic variations in hairy cell leukemia,” American Journal of Clinical Pathology, vol. 125, no. 2, pp. 251–259, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. M. J. Sherman, C. A. Hanson, and J. D. Hoyer, “An assessment of the usefulness of immunohistochemical stains in the diagnosis of hairy cell leukemia,” American Journal of Clinical Pathology, vol. 136, no. 3, pp. 390–399, 2011. View at Google Scholar
  6. D. W. Warden, S. Ondrejka, J. Lin, L. Durkin, J. Bodo, and E. D. Hsi, “Phospho-ERK Thr202/Tyr214 is overexpressed in hairy cell leukemia and is a useful diagnostic marker in bone marrow trephine sections,” American Journal of Surgical Pathology, vol. 37, no. 2, pp. 305–308, 2013. View at Google Scholar
  7. E. Tiacci, G. Schiavoni, M. P. Martelli et al., “Constant activation of the RAF-MEK-ERK pathway as a diagnostic and therapeutic target in hairy cell leukemia,” Haematologica, vol. 98, no. 4, pp. 635–639, 2013. View at Publisher · View at Google Scholar
  8. S. Schnittger, U. Bacher, T. Haferlach et al., “Development and validation of a real-time quantification assay to detect and monitor BRAF V600E mutations in hairy cell leukemia,” Blood, vol. 119, no. 13, pp. 3151–3154, 2012. View at Google Scholar
  9. L. Xi, E. Arons, W. Navarro et al., “Both variant and IGHV4-34-expressing hairy cell leukaemia lack the BRAF V600E mutation,” Blood, vol. 119, no. 14, pp. 3330–3332, 2012. View at Google Scholar
  10. H. Shao, K. R. Calvo, M. Grönborg et al., “Distinguishing hairy cell leukemia variant from hairy cell leukemia: development and validation of diagnostic criteria,” Leukemia Research, vol. 37, no. 4, pp. 401–409, 2013. View at Google Scholar
  11. S. Dietrich, H. Glimm, M. Andrulis, C. von Kalle, A. D. Ho, and T. Zenz, “BRAF inhibition in refractory hairy-cell leukemia,” The New England Journal of Medicine, vol. 366, no. 21, pp. 2038–2040, 2012. View at Google Scholar
  12. G. A. Follows, H. Sims, D. M. Bloxham et al., “Rapid response of biallelic BRAF V600E mutated hairy cell leukaemia to low dose vemurafenib,” British Journal of Haematology, vol. 161, no. 1, pp. 150–153, 2013. View at Google Scholar
  13. F. Peyrade, D. Re, C. Ginet et al., “Low-dose vemurafenib induces complete remission in a case of hairy-cell leukemia with a V600E mutation,” Haematologica, vol. 98, no. 2, pp. e20–e22, 2013. View at Google Scholar